Phase Clinical Services
Phase Clinical Services is a full-service oncology CRO specializing in Phase 0-II clinical trials and biospecimen procurement. They focus on accelerating drug development, reducing costs, and improving success rates in oncology research through expertise in adaptive trial design, operational management, and access to a global network of hospitals and patients. Their mission is to support biotech, pharma, and medical device developers with faster, more cost-effective clinical trials, ensuring high-quality data and successful outcomes.
Industries
Nr. of Employees
small (1-50)
Phase Clinical Services
New York, New York, United States, North America
Products
Patient availability calculator
Online tool to estimate potential patient enrollment for oncology clinical trials by cancer type and stage using network-derived patient data.
Biospecimen inventory and prospective collections
Catalog and procurement service for human biospecimens (blood, FFPE, frozen tissue, primary cells) with associated clinical and pathology metadata.
Patient availability calculator
Online tool to estimate potential patient enrollment for oncology clinical trials by cancer type and stage using network-derived patient data.
Biospecimen inventory and prospective collections
Catalog and procurement service for human biospecimens (blood, FFPE, frozen tissue, primary cells) with associated clinical and pathology metadata.
Services
Design and documentation of clinical trial protocols including objectives, methodology, analysis plans, and enrollment strategies.
Identification, contracting, and management of hospital sites in a multi-country network for oncology trials.
Preparation and expedited submission of IRB applications and amendments using established local networks.
Operational recruitment across network sites supported by a patient availability tool and searchable datasets.
Local monitoring, SDV, and ongoing communication with site staff to ensure protocol adherence and data quality.
Clinical data integration, quality control, and statistical analysis using recognized data standards.
Design and documentation of clinical trial protocols including objectives, methodology, analysis plans, and enrollment strategies.
Identification, contracting, and management of hospital sites in a multi-country network for oncology trials.
Preparation and expedited submission of IRB applications and amendments using established local networks.
Operational recruitment across network sites supported by a patient availability tool and searchable datasets.
Local monitoring, SDV, and ongoing communication with site staff to ensure protocol adherence and data quality.
Clinical data integration, quality control, and statistical analysis using recognized data standards.
Expertise Areas
- Oncology clinical trial management
- Adaptive trial design
- Biospecimen procurement and biobanking
- Biomarker testing and companion diagnostics
Key Technologies
- Next-generation sequencing (WGS/WES)
- Oncology biomarker panels
- Immunohistochemistry for PD-L1 and tissue biomarkers
- CDISC Define-XML and clinical data standards
News & Updates
June 16-19, 2025, Boston Convention & Exhibition Center. See event website.
July 27-31, 2025, McCormick Place Convention Center, Chicago, IL. See event website.
A study by Phase Clinical and the FDA on PD-L1 expression patterns in lung cancer tissues, presented at the SITC Annual Meeting.
Completed COVID Study for FDA EUA
Successfully completed a COVID-19 clinical study to enable FDA Emergency Use Authorization for a point of care antigen detection assay for SARS-CoV-2.
June 16-19, 2025, Boston Convention & Exhibition Center. See event website.
July 27-31, 2025, McCormick Place Convention Center, Chicago, IL. See event website.
A study by Phase Clinical and the FDA on PD-L1 expression patterns in lung cancer tissues, presented at the SITC Annual Meeting.
Completed COVID Study for FDA EUA
Successfully completed a COVID-19 clinical study to enable FDA Emergency Use Authorization for a point of care antigen detection assay for SARS-CoV-2.